Infectious Disease Point of Care Diagnostics Market to Reach $3371.1 Million by 2027; Increasing R&D Investments and Rising Research Activities have Widened the Application Scope for the Product, says Fortune Business Insights™

Infectious Disease Point of Care Diagnostics Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast latest study published by Fortune Business Insights. The global “infectious disease point of care (PoC) diagnostics market” size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth.

According to a report published by Fortune Business Insights, titled “Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test, Molecular Diagnostics, and Others), By Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV), Influenza, Clostridium Difficile Infections (CDI), Hepatitis C Virus, Methicillin Resistant Staphylococcus Aureus (MRSA), Tuberculosis, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home & Self-Testing, Nursing Homes, and Others), and Regional Forecast, 2020-2027” the market was worth USD 1246.5 million and will exhibit a CAGR of 17.4% during the forecast period, 2020-2027.

Point of care (PoC) testing allows faster diagnosis of diseases at the patient site itself. The drawbacks of conventional diagnostic methods including time to test, inefficiency, and non-portability can be overcome through infectious disease PoC diagnosis. Recent technological advances have opened up a massive potential for the growth of the market in the past few years. The increasing popularity of this concept is consequential to the rapid technological advances. The increasing product demand has encouraged companies to invest higher upfront capital. The sector holds a huge potential for entry-level as well as mid-sized companies across the world. Additionally, increasing research activities will also emerge in favor of market growth in the forthcoming years.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/sample/infectious-disease-point-of-care-poc-diagnostics-market-104307

This report focuses on Infectious Disease Point of Care Diagnostics Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.

Covid-19 Pandemic to Create Massive Opportunities for Rapid Market Growth
The recent coronavirus outbreak has created a sense of panic and urgency across the world. The pandemic has had a drastic impact on several economies across the globe, with SMEs being affected the most. With only large-scale companies being able to sustain the drawbacks of the pandemic in a seamless manner, it is evident that these companies will look to adopt newer strategies to recover the losses in the past few months. The use of several PoC diagnostic test kits has risen dramatically in the past few months, given the ability of the product to generate results in a time span that is lesser than 30 mins. Having said that, major attention has been given to the SARS-Cov-2 infection and other diagnostic products have been kept on hold. As a result, the Covid-19 pandemic has brought mixed fortunes for companies in the infectious disease PoC diagnostics market.

Increasing Product Use during Covid-19 Pandemic will Emerge in Favor of Market Growth
The report encompasses several factors that have contributed to the growth of the overall market in recent years. The massive investments in infectious disease PoC diagnostics have yielded a few exceptional products, enabling applications across diverse treatment procedures. The product has also been put to use in detecting symptoms of Covid-19 in the ongoing pandemic. Several large-scale companies are looking to maximize the use of the product during the pandemic and as a result, the investments in PoC diagnostics has gone up considerably in the past few months. In May 2020, Quest Diagnostics announced that it has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its self-collection antibody test kits. The product is used for test kit for Covid-19 for patients looking to get tested from home. Increasing number of product innovations will have a huge impact on the growth of the overall market in the coming years.

Quick Buy - Infectious Disease Point of Care Diagnostics Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/104307

North America to Emerge Dominant; Growing Penetration of Advanced PoC Diagnostics will Emerge in Favor of Market Growth
The report analyzes the ongoing market trends across North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing adoption of advanced PoC diagnostics, especially in the United States, has contributed to the growth of the regional market. The increasing Covid-19 cases has also given the platform for companies in the infectious disease PoC diagnostics sector. As of 2019, the market in North America was worth USD 457.2 million and this value is projected to rise at a considerable pace in the coming years. The market in Europe held the second largest share, following North America in the global market.

List of companies profiled in the report:
• F. Hoffmann-La Roche Ltd (Basel, Switzerland)
• Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
• Abbott Laboratories (Illinois, U.S)
• Quest Diagnostics Incorporated (New Jersey, United States)
• BD (Franklin Lakes, U.S)
• bioMérieux SA (Marcy l'Etoile, France)
• Cardinal Health, Inc. (Ohio, U.S)
• Mesa Biotech (California, U.S)
• Cepheid (California, U.S)
• Trinity Biotech (Bray, Ireland)
• Quidel Corporation (San Diego, U.S.)
• Bio-Rad Laboratories Inc. (California, U.S)
• Other Players

Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/infectious-disease-point-of-care-poc-diagnostics-market-104307

Industry Developments:
June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.

Global Infectious Disease Point of Care Diagnostics Market Segmentation :

By Technique
• Lateral Flow Immunoassay (LFIA)
• Agglutination Test
• Flow-through test/Immunoconcentration Assay
• Molecular Diagnostics
• Others

By Disease
• HIV
• Hepatitis B Virus
• Pneumonia/Streptococcus Associated Infections
• Respiratory Syncytial Virus (RSV)
• Influenza
• Clostridium Difficile Infections (CDI)
• Hepatitis C Virus
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Tuberculosis (TB)
• Others

By End User
• Hospital Bedside
• Physician's Office Lab
• Urgent Care & Retail Clinics
• Home & Self-testing
• Nursing Home
• Others

By Geography
• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table of Content:

1 Infectious Disease Point of Care Diagnostics Market Overview
1.1 Infectious Disease Point of Care Diagnostics Product Overview
1.2 Infectious Disease Point of Care Diagnostics Market Segment by Type
1.3 Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2027)
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Size Overview by Type (2015-2027)
1.3.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Infectious Disease Point of Care Diagnostics Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.2 Europe Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
2 Global Infectious Disease Point of Care Diagnostics Market Competition by Company
2.1 Global Top Players by Infectious Disease Point of Care Diagnostics Sales (2015-2021)
2.2 Global Top Players by Infectious Disease Point of Care Diagnostics Revenue (2015-2021)
2.3 Global Top Players Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Infectious Disease Point of Care Diagnostics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Infectious Disease Point of Care Diagnostics Market Competitive Situation and Trends
2.5.1 Infectious Disease Point of Care Diagnostics Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Infectious Disease Point of Care Diagnostics Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
2.7 Date of Key Company Enter into Infectious Disease Point of Care Diagnostics Market
2.8 Key Company Infectious Disease Point of Care Diagnostics Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Infectious Disease Point of Care Diagnostics Status and Outlook by Region (2015-2027)
3.1 Global Infectious Disease Point of Care Diagnostics Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2015-2021)
3.2.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share by Region (2015-2021)
3.2.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2015-2021)
3.2.3 Global Infectious Disease Point of Care Diagnostics Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2021-2027)
3.3.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share by Region (2021-2027)
3.3.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2021-2027)
3.3.3 Global Infectious Disease Point of Care Diagnostics Sales, Revenue, Price and Gross Margin (2021-2027)
3.4 North America Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.4.1 North America Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.4.2 North America Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.5 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.5.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.5.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.6 Europe Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.6.1 Europe Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.6.2 Europe Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.7 Latin America Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.7.1 Latin America Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.7.2 Latin America Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.8 Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.8.1 Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.8.2 Middle East and Africa Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
4 Global Infectious Disease Point of Care Diagnostics by Application
4.1 Infectious Disease Point of Care Diagnostics Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Infectious Disease Point of Care Diagnostics Sales by Application: 2015 VS 2021 VS 2027
4.3 Global Infectious Disease Point of Care Diagnostics Historic Sales by Application (2015-2021)
4.4 Global Infectious Disease Point of Care Diagnostics Forecasted Sales by Application (2021-2027)
4.5 Key Regions Infectious Disease Point of Care Diagnostics Market Size by Application
4.5.1 North America Infectious Disease Point of Care Diagnostics by Application
4.5.2 Europe Infectious Disease Point of Care Diagnostics by Application
4.5.3 Asia-Pacific Infectious Disease Point of Care Diagnostics by Application
4.5.4 Latin America Infectious Disease Point of Care Diagnostics by Application
4.5.5 Middle East and Africa Infectious Disease Point of Care Diagnostics by Application
5 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
5.1.2 North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2027)
5.2.1 North America Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
5.2.2 North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
5.3.2 Canada Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
6.1.2 Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2027)
6.2.1 Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
6.2.2 Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.2 France Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.3 U.K. Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.4 Italy Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.5 Russia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)
7.1.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
7.1.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)
7.2.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
7.2.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
7.3 Asia-Pacific Market Size By Growth by Country
7.3.1 China Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.2 Japan Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.3 South Korea Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.4 India Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.5 Australia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.6 Taiwan Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.7 Indonesia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.8 Thailand Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.9 Malaysia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.10 Philippines Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)

Toc Continue…

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

This release was published on openPR.